Skip to main content

Health Area: Rare disease

Equipping country affiliates to engage effectively with policy makers on the evolving field of real-world evidence​​

Rabin Martin helped a major pharmaceutical company lay the foundation for effective stakeholder engagement in advancing the use of real-world evidence in regulatory and HTA decision-making​.

Establishing a leadership platform in rare disease

Rabin Martin designed and supported Takeda’s signature initiative to reduce the time to diagnosis for children with a rare disease: Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease.